Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, stock availability, or time-slot availability.
    Difference
    0.1%
    Check dated 2025-09-14T19:12:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T15:27:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed location information for various cities across multiple countries, as well as the inclusion of specific medical terms related to renal cell carcinoma and Tivozanib Hydrochloride. Notably, the facility name and location details have been clarified and expanded.
    Difference
    13%
    Check dated 2025-08-31T11:53:58.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:18:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:19:20.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-02T18:41:55.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.